Cipla Ltd. | CIPLA | NSE - Pharmaceuticals
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..
Upgrade Membership to see 10 year accurate financial statements.
Chart | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|
Revenue |
| 163,624 | 171,320 | 191,596 | 217,633 | 227,531 |
Cost of revenue |
| -57,845 | -59,914 | -73,519 | -84,956 | -82,523 |
Gross Profit |
| 105,779 | 111,406 | 118,077 | 132,677 | 145,008 |
Sales, general & ad... |
| -74,806 | -79,346 | -75,553 | -87,150 | -94,739 |
Depreciation |
| -13,263 | -11,747 | -10,677 | -10,520 | -11,721 |
Provision |
| 0 | 0 | 0 | 0 | 0 |
Other op inc/exp... |
| 0 | 0 | 0 | 0 | 0 |
Operating income |
| 17,710 | 20,313 | 31,848 | 35,008 | 38,549 |
Profit before tax |
| 20,791 | 21,782 | 32,901 | 34,933 | 40,384 |
Net Income |
| 15,277 | 15,470 | 24,049 | 25,467 | 28,329 |
| | | | | ||
EPS Basic |
| 18.97 | 19.19 | 29.84 | 31.20 | 34.72 |